Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTWhat's new for in-clinic hematology?Advancements in diagnostics provide greater opportunities to predict, prevent, diagnose and treat animal illnesses, more quickly, accurately and reliably. In hematology, new AI-powered technologies can help to elevate patient care and streamline workflows – driving meaningful change in the veterinary practice. +